Target intelligence / Profile preview

Parasite heme detoxification pathway

Molecular classification
Enzyme, Metabolic pathway, Other
01

Overview

The parasite heme detoxification pathway is a critical metabolic process utilized by Plasmodium species during their intraerythrocytic life cycle stage (Francis et al., 1997). As the parasite digests host hemoglobin to acquire essential amino acids, it releases large quantities of free heme (ferriprotoporphyrin IX), which is highly toxic due to its ability to generate reactive oxygen species and disrupt cellular membranes (Egan et al., 2002). To mitigate this toxicity, the parasite converts free heme into an insoluble, chemically inert crystalline polymer known as hemozoin, or malaria pigment (Pagola et al., 2000). This biocrystallization process is primarily mediated by the Heme Detoxification Protein (HDP) and occurs within the parasite's acidic digestive vacuole (Jani et al., 2008). Many classic antimalarial drugs, particularly the quinoline class such as chloroquine and quinine, exert their therapeutic effect by binding to heme monomers or the growing crystal surface, thereby inhibiting polymerization (Sullivan et al., 1996). The resulting accumulation of toxic free heme leads to oxidative damage and the eventual death of the parasite, making this pathway one of the most successful targets in the history of antimalarial chemotherapy.

Other names
Parasite heme / hemozoin crystallization pathwayHemozoin crystallization pathwayHeme biocrystallizationMalaria pigment formationHeme detoxificationHeme polymerization pathway
02

Mechanism of action

Inhibition of heme polymerization into hemozoin crystals, resulting in the accumulation of toxic free ferriprotoporphyrin IX (FP) within the parasite (Sullivan et al., 1996). Artemisinins may also interact with heme to generate toxic free radicals (Cui & Su, 2009).

03

Biological functions

Heme detoxificationMetabolic waste managementOther
04

Disease associations

Infection
05

Safety considerations

Drug resistance mediated by PfCRT and PfMDR1 transportersRetinal toxicityCardiotoxicity (QT prolongation)Neurotoxicity
06

Interacting drugs

Chloroquine

8 more in the full profile.

07

Biomarkers

Hemozoin levelsParasitemiaHeme detoxification protein (HDP) expressionParasite-specific lactate dehydrogenase (pLDH)

Beyond the preview

Go deeper on Parasite heme detoxification pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Parasite heme detoxification pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call